艾斯特拉泽内卡的新型肺炎药物在临床试验中取得了强的成绩. AstraZeneca's new COPD drug shows strong clinical trial results.

艾斯特拉泽内卡的新型COPD药物在关键临床试验中显示出强的结果,表明其对治疗肺部疾病有潜在改善. AstraZeneca’s new COPD drug showed strong results in key clinical trials, signaling potential improvements for treating the lung condition.